Multi-center, Investigator Initiated Phase 1 Study of MAGE-A4 Specific TCR Gene Transferred T Lymphocytes With Solid Tumors
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs TBI 1201 (Primary) ; Cyclophosphamide; Fludarabine
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Takara Bio
- 19 Oct 2018 Planned End Date changed from 30 Jun 2018 to 31 Mar 2019.
- 19 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Nov 2017 Planned End Date changed to 30 Jun 2018.